The Goldman Sachs Group Trims Singular Genomics Systems (NASDAQ:OMIC) Target Price to $0.85

Singular Genomics Systems (NASDAQ:OMIC – Free Report) had its price objective cut by The Goldman Sachs Group from $0.95 to $0.85 in a research note published on Monday, Benzinga reports. They currently have a neutral rating on the stock. Singular Genomics Systems Stock Performance OMIC opened at $0.43 on Monday. The stock has a market […]

Related Keywords

Elin Glezer , ,Singular Genomics Systems Inc ,Goldman Sachs Group ,Balyasny Asset Management ,Proshare Advisors ,Capital Management ,Millennium Management ,Singular Genomics Systems Company Profile ,Singular Genomics Systems ,Free Report ,Genomics Systems ,Get Free Report ,Singular Genomics ,Asset Management ,Share Advisors ,Singular Genomics Systems Daily ,Nasdaq Omic ,Comic ,Medical ,Lower Price Target ,The Goldman Sachs Group Inc ,